CNBC Daily Open: Wishing upon a meteor that tariffs won’t cause inflation

CNBC Daily Open: Wishing upon a meteor that tariffs won’t cause inflation


Containers sit at the Port of Los Angeles, in San Pedro, California, U.S., July 8, 2025.

Daniel Cole | Reuters

U.S. President Donald Trump announced Tuesday that copper and pharmaceutical imports will face tariffs of 50% and as high as 200%, respectively.

Following the news, the S&P 500, which hit multiple record closes last week, ground to a halt and closed mostly flat.

That said, it’s a muted response for such hefty tariffs, suggesting investors are either brushing off Trump’s tariffs as hollow threats, or discounting the effects they could have on inflation and the economy.  

Such complacency could be a mistake, as some market watchers have cautioned. It also mirrors the White House’s stance on the effects of tariffs, which might not be a position investors want to take.

On Tuesday, Stephen Miran, chairman of Trump’s Council of Economic Advisers, told CNBC’s “Squawk Box” that the odds of tariffs leading to higher prices is a “rare event” like “pandemics or, or meteors or whatever.”

“I don’t mean to be dismissive,” Miran clarified. “All I mean to say is that prediction is difficult, and we should always speak in terms of odds and possibilities.”

For the record, there’s a 0.004% chance of an asteroid that will fly near Earth in 2023 striking our planet, according to NBC News.

What you need to know today

And finally…

Traders work on the New York Stock Exchange floor on Dec. 18, 2024.

Spencer Platt | Getty Images

Global stock markets’ best and worst performers in a Trump-fueled 2025 — and where they’re headed

Global stocks have surged in the first half of 2025, even as U.S. President Donald Trump announced steep tariffs on imports to the United States. The MSCI All Country World Index, which measures the performance of more than 2,500 stocks from both developed and emerging market equities, rose nearly 10% since the start of the year to hit a record high on July 4.

“The global trade war that the U.S. started has been, and will continue to be, the catalyst for this ex-U.S. outperformance,” said Peter Boockvar, chief investment officer at Bleakley Financial Group.

— Lee Ying Shan



Source

Merck shells out  billion for London-based lung therapy firm Verona
World

Merck shells out $10 billion for London-based lung therapy firm Verona

Bloomberg | Bloomberg | Getty Images Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug. Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, […]

Read More
Singapore state investor Temasek is rethinking defense as a strategic ESG bet
World

Singapore state investor Temasek is rethinking defense as a strategic ESG bet

Defense stocks are booming — and according to one of Asia’s biggest investors, allocating capital to the sector doesn’t mean having to abandon ESG initiatives. Speaking to CNBC’s Martin Soong on Wednesday, Rohit Sipahimalani, chief investment officer at Singapore’s state investment fund Temasek, said his team were looking at opportunities in the European defense sector. […]

Read More
Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push
World

Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push

Smart Ray-Ban Glasses, on June 16, 2024, in Caen, Normandy, France. Nurphoto | Getty Images Shares of Ray-Ban maker EssilorLuxottica almost 6% on Wednesday on reports that Meta has taken a minority stake in the company amid growing appetite for AI-powered wearable devices. Meta reportedly bought a stake worth around 3 billion euros ($3.51 billion) […]

Read More